Immatics at the Informa's Cell Therapy Manufacturing and Gene Therapy (Dec 6 – Dec 7) in Amsterdam, Netherlands

We look forward to seeing you at The Cell Therapy Manufacturing and Gene Therapy Congress soon!

Steffen Walter, CSO of Immatics US, speaks on Wednesday, December 6 on how to use the antigen discovery platform XPRESIDENT® to identify and rank shared antigens, neoantigens as well as novel classes of antigens such as cryptic epitopes or RNA-edited epitopes:

 
Wednesday, Dec 6, 11.50am
Talk: Novel targets and T-cell receptors for adoptive cell therapy
Presenter: Steffen Walter (CSO)

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back